HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kelly A Foley Selected Research

propionic acid (potassium propionate)

1/2020Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats.
1/2019Systemic treatment with the enteric bacterial metabolic product propionic acid results in reduction of social behavior in juvenile rats: Contribution to a rodent model of autism spectrum disorder.
2/2015Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders.
12/2014Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders.
2/2012Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats.
4/2010Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kelly A Foley Research Topics

Disease

5Onychomycosis (Tinea Unguium)
05/2021 - 12/2014
5Autism Spectrum Disorder
01/2020 - 04/2010
3Infections
05/2021 - 11/2014
3Alopecia (Baldness)
11/2019 - 11/2014
2Mycoses (Diseases, Fungus)
02/2017 - 02/2015
2Pain (Aches)
08/2013 - 02/2013
1Tinea Capitis
02/2017
1Tinea (Ringworm)
02/2017
1Reinfection
03/2015
1Candidiasis (Moniliasis)
12/2014
1Neurodevelopmental Disorders
12/2014
1Musculoskeletal Pain
08/2013
1Wounds and Injuries (Trauma)
08/2013
1Hyperalgesia
02/2013
1Obesity
02/2012
1Cognitive Dysfunction
10/2011
1Autistic Disorder (Autism)
04/2010
1Bacterial Infections (Bacterial Infection)
10/2007

Drug/Important Bio-Agent (IBA)

6propionic acid (potassium propionate)IBA
01/2020 - 04/2010
3Terbinafine (Lamisil)FDA LinkGeneric
05/2021 - 02/2017
3Itraconazole (Sporanox)FDA LinkGeneric
05/2021 - 02/2017
3Minoxidil (Rogaine)FDA LinkGeneric
11/2019 - 11/2014
3Volatile Fatty AcidsIBA
01/2019 - 04/2010
2Pharmaceutical PreparationsIBA
05/2021 - 03/2017
2LipopolysaccharidesIBA
02/2015 - 12/2014
1N-desmethylstobadineIBA
05/2021
1squaric acid dibutyl esterIBA
11/2019
1tofacitinibIBA
11/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019
1Fluconazole (Zonal)FDA LinkGeneric
02/2017
1Antifungal AgentsIBA
02/2017
1Griseofulvin (Grifulvin V)FDA LinkGeneric
02/2017
1Finasteride (Propecia)FDA LinkGeneric
02/2017
1Ketoconazole (Nizoral)FDA LinkGeneric
02/2015
1Ciclopirox (Loprox)FDA LinkGeneric
12/2014
1amorolfineIBA
12/2014
1efinaconazoleIBA
12/2014
1tavaboroleIBA
12/2014
1dalbavancinIBA
11/2014
1GlucocorticoidsIBA
08/2013
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
08/2013
1Tacrolimus Binding Proteins (FKBP)IBA
08/2013
1DNA (Deoxyribonucleic Acid)IBA
08/2013
1Opioid Receptors (Opioid Receptor)IBA
02/2013
1Opioid Analgesics (Opioids)IBA
02/2013
1Anti-Anxiety Agents (Anxiolytics)IBA
10/2011
1salicylhydroxamic acid (SHAM)IBA
10/2011
1LipidsIBA
04/2010
1acylcarnitineIBA
04/2010
1Phospholipids (Phosphatides)FDA LinkGeneric
04/2010
1Dopamine (Intropin)FDA LinkGeneric
10/2007

Therapy/Procedure

4Therapeutics
02/2017 - 12/2014
3Lasers (Laser)
11/2019 - 03/2017
1Low-Level Light Therapy (LLLT)
02/2017
1Intraventricular Infusions
04/2010